HomeCompareSPPH vs XYLD

SPPH vs XYLD: Dividend Comparison 2026

SPPH yields 2000000.00% · XYLD yields 10.98%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 SPPH wins by $4.879226400974806e+39M in total portfolio value
10 years
SPPH
SPPH
● Live price
2000000.00%
Share price
$0.00
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$4.879226400974806e+39M
Annual income
$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00
Full SPPH calculator →
XYLD
Global X S&P 500 Covered Call ETF
● Live price
10.98%
Share price
$39.13
Annual div
$4.30
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$25.3K
Annual income
$3,219.02
Full XYLD calculator →

Portfolio growth — SPPH vs XYLD

📍 SPPH pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodSPPHXYLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, SPPH + XYLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
SPPH pays
XYLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

SPPH
Annual income on $10K today (after 15% tax)
$170,000,000.00/yr
After 10yr DRIP, annual income (after tax)
$4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/yr
XYLD
Annual income on $10K today (after 15% tax)
$933.63/yr
After 10yr DRIP, annual income (after tax)
$2,736.17/yr
At 15% tax rate, SPPH beats the other by $4,146,934,558,431,324,500,000,000,000,000,000,000,000,000,000.00/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of SPPH + XYLD for your $10,000?

SPPH: 50%XYLD: 50%
100% XYLD50/50100% SPPH
Portfolio after 10yr
$2.439613200487403e+39M
Annual income
$2,439,373,269,665,485,000,000,000,000,000,000,000,000,000,000.00/yr
Blended yield
99.99%
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

SPPH buys
0
XYLD buys
0
No recent congressional trades found for SPPH or XYLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricSPPHXYLD
Forward yield2000000.00%10.98%
Annual dividend / share$2.00$4.30
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%0%
Portfolio after 10y$4.879226400974806e+39M$25.3K
Annual income after 10y$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$3,219.02
Total dividends collected$4.879195005460081e+39M$19.6K
Payment frequencyquarterlymonthly
SectorStockETF

Year-by-year: SPPH vs XYLD ($10,000, DRIP)

YearSPPH PortfolioSPPH Income/yrXYLD PortfolioXYLD Income/yrGap
1← crossover$200,010,700$200,000,000.00$10,818$1,098.39+$200.00MSPPH
2$3,738,731,768,458$3,738,517,757,009.35$11,738$1,222.51+$3738731.76MSPPH
3$65,315,062,866,930,490$65,311,062,423,938,240.00$12,774$1,364.64+$65315062866.92MSPPH
4$1,066,400,830,062,625,000,000$1,066,330,942,945,357,500,000.00$13,944$1,527.86+$1066400830062625.00MSPPH
5$16,272,182,796,453,826,000,000,000$16,271,041,747,565,660,000,000,000.00$15,270$1,715.87+$16272182796453826560.00MSPPH
6$232,054,240,113,661,900,000,000,000,000$232,036,828,878,069,680,000,000,000,000.00$16,775$1,933.09+$2.3205424011366188e+23MSPPH
7$3,092,799,066,104,688,500,000,000,000,000,000$3,092,550,768,067,767,400,000,000,000,000,000.00$18,490$2,184.87+$3.0927990661046884e+27MSPPH
8$38,524,105,697,352,694,000,000,000,000,000,000,000$38,520,796,402,351,967,000,000,000,000,000,000,000.00$20,450$2,477.63+$3.8524105697352695e+31MSPPH
9$448,468,826,014,798,700,000,000,000,000,000,000,000,000$448,427,605,221,702,600,000,000,000,000,000,000,000,000.00$22,697$2,819.19+$4.484688260147987e+35MSPPH
10$4,879,226,400,974,806,000,000,000,000,000,000,000,000,000,000$4,878,746,539,330,970,000,000,000,000,000,000,000,000,000,000.00$25,280$3,219.02+$4.879226400974806e+39MSPPH

SPPH vs XYLD: Complete Analysis 2026

SPPHStock

Spencer Pharmaceutical Inc. develops drug platform technologies for the treatment of neurological deceases. The company specializes in the controlled release of existing therapeutic molecules in the areas of central nervous system, which include Alzheimer and Parkinson diseases, and brain cancer; and patented slow release drug delivery technology for the treatment of type-2 diabetes, arthritis, and other potential applications. It has operations primarily in North America and Europe. The company was incorporated in 1998 and is based in Boston, Massachusetts.

Full SPPH Calculator →

XYLDETF

The Global X S&P 500 Covered Call ETF (XYLD) seeks to provide investment results that correspond generally to the price and yield performance, before fees and expenses, of the Cboe S&P 500 BuyWrite Index.

Full XYLD Calculator →
📬

Get this SPPH vs XYLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

SPPH vs SCHDSPPH vs JEPISPPH vs OSPPH vs KOSPPH vs MAINSPPH vs QYLDSPPH vs JEPQSPPH vs RYLD

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.